Caption Management’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$313K Buy
+43,200
New +$563K ﹤0.01% 1293
2025
Q4
Sell
-12,000
Closed -$122K 2126
2025
Q3
$87.8K Buy
+12,000
New +$97.1K ﹤0.01% 1541
2025
Q2
Sell
-43,501
Closed -$287K 1960
2025
Q1
$351K Buy
43,501
+4,401
+11% +$48.1K ﹤0.01% 1179
2024
Q4
$484K Buy
+39,100
New +$522K ﹤0.01% 1114
2021
Q2
Sell
-87,957
Closed -$493K 1611
2021
Q1
$493K Buy
+87,957
New +$845K 0.01% 809
2020
Q1
Sell
-36,000
Closed -$289K 1112
2019
Q4
$289K Sell
36,000
-44,000
-55% -$1.08M 0.01% 691
2019
Q3
$1.64M Sell
80,000
-600
-0.7% -$13.8K 0.09% 280
2019
Q2
$2.1M Buy
+80,600
New +$2.26M 0.11% 234

Other funds holding WVE

Caption Management's WVE Position: Q1 2026 in Review

Caption Management opened a new position in Wave Life Sciences (WVE) in Q1 2026: 43,200 shares worth $313K. The stake represents ﹤0.01% of the portfolio and ranks #1293 among its holdings. This is a return to the name: Caption Management previously reported a position in WVE as recently as Q3 2025.

Caption Management first reported a position in WVE in Q2 2019 and has held it in 8 quarters since. The position peaked at $2.1M in Q2 2019. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Caption Management held 43,200 shares of Wave Life Sciences worth $313K as of Q1 2026.
  • Wave Life Sciences was a new Caption Management position in Q1 2026.
  • Wave Life Sciences made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1293 holding.
  • Caption Management first reported a position in Wave Life Sciences in Q2 2019 and has held it in 8 quarters since.
  • Caption Management's Wave Life Sciences position peaked at $2.1M in Q2 2019.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.